Amphastar Pharmaceuticals, Inc.
- AMPH
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Generic Injectables/Complex Generics
$26.14
Today +1.04%Quote Oct 19, 2026, 08:00 PM UTC
+10.67%over the last month
Max drawdown −7.4%From 1-month high −4.6%3 months +33.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations.
Where the money comes from
Q2 2026 revenue $183.9M
- Other Products$66.2M36.0%
- BAQSIMI$45.5M24.7%
- Primatene MIST$21.0M11.4%
- Epinephrine$15.9M8.6%
- Lidocaine$15.0M8.2%
- Glucagon$11.9M6.5%
- Ipratropium Bromide Member$8.4M4.6%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
1,976
Market value
$1.11B
Quote Oct 19
Floor
$25.20
3.6% below price
Resistance
$26.16
0.1% above price
Price vs analyst targets
12 analysts
Lowest target
$19.00Highest target
$23.00
$19.00Highest target
$23.00
- Price $26.14
- Average target $21.25
- Analysts' target range
The price is above even the highest analyst target. Analysts' average target sits about 19% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AMPHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free